The Food and Drug Administration is considering adding warning labels to antidepressants for women who are pregnant, despite ...

Federal regulators have been scrutinizing kratom for about a decade after reports of addiction, injury and overdose ...

The Food and Drug Administration is considering adding warning labels to antidepressants for people who are pregnant, despite ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

The US Food and Drug Administration recently convened a panel of experts to examine a sensitive and increasingly urgent ...

Last Monday, an expert panel convened by the U.S. Food and Drug Administration (FDA) to discuss the use of selective ...

Leading medical experts have called for women to stop taking antidepressants during pregnancy over fears that they could ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not easing — the nation’s depression rates.

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

As Covid cases begin to rise this summer, many may be wondering: What are my risks, and is it time to get another vaccine? As ...

The U.S. Food and Drug Administration is turning its attention to selective serotonin reuptake inhibitors, a class of antidepressant drugs long criticized by Health and Human Services ...

The FDA convened experts to reevaluate SSRI use during pregnancy, sparking debate over antidepressant safety, fetal risks, ...